Related Experiment Video
Updated: Aug 11, 2026
New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
Published on: May 30, 2013
Rethinking CD4+ T cell counts for individuals who recently seroconverted to human immunodeficiency virus
1Department of Internal Medicine, Naval Medical Center, San Diego, California, USA.
Insights
Newly diagnosed human immunodeficiency virus (HIV) patients show a wide range of CD4+ T lymphocyte counts. Early assessment is crucial, as some individuals may need immediate antiretroviral therapy or antibiotics.
Area of Science:
- Immunology
- Virology
- Public Health
Background:
- CD4+ T lymphocyte counts are a key indicator of immune system health.
- Human immunodeficiency virus (HIV) infection significantly impacts CD4+ T cell levels.
- Recent seroconversion indicates the early stage of HIV infection.
Purpose of the Study:
- To review the distribution of initial CD4+ T lymphocyte counts in individuals recently infected with HIV.
- To discuss factors contributing to variability in CD4+ T cell counts during early HIV infection.
- To highlight the clinical significance of early CD4+ T cell assessment for treatment decisions.
Main Methods:
- Systematic review of major articles on CD4 cell counts post-HIV documentation.
- Analysis of studies reporting CD4 counts shortly after seroconversion.
- Discussion of sources of variability in reported CD4 counts.
Main Results:
- The distribution of initial CD4+ T lymphocyte counts in recently HIV-seroconverted individuals is broad.
- Significant variability exists in CD4+ T cell counts among recently infected patients.
- Some recently infected individuals present with low CD4+ T cell counts.
Conclusions:
- Recognizing the broad distribution of initial CD4+ T cell counts is clinically important.
- Early identification of low CD4+ T cell counts in recent HIV infection is essential for timely intervention.
- Patients with low CD4+ T cell counts may require immediate antiretroviral agents or prophylactic antibiotics.
Abstract:
The distribution of initial CD4+ T lymphocyte counts for individuals who have recently seroconverted to human immunodeficiency virus (HIV) is broad. We review major articles describing CD4 cell counts shortly after documented HIV infection and discuss both the possible sources of variability in these studies and the clinical importance of recognizing that even recently infected patients may have low CD4 cell counts and thus will require therapeutic intervention with antiretroviral agents or prophylactic antibiotics.
